Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs

Beatrice J Edwards; John W Hellstein; Peter L Jacobsen; Steven Kaltman; Angelo Mariotti; Cesar A Migliorati

doi:10.14219/jada.archive.2008.0110

Back

Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs

Journal article

Peer reviewed

Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs

Beatrice J Edwards, John W Hellstein, Peter L Jacobsen, Steven Kaltman, Angelo Mariotti and Cesar A Migliorati

The Journal of the American Dental Association (1939), Vol.139(12), pp.1674-1677

12/2008

DOI: 10.14219/jada.archive.2008.0110

PMID: 19047674

View Online

Abstract

and Overview. In 2005, the American Dental Association (ADA) Council on Scientific Affairs convened an expert panel to develop clinical recommendations for dentists treating patients who are receiving oral bisphosphonate therapy. The Journal of the American Dental Association published the resulting report in 2006. This 2008 advisory statement is the first of projected periodic updates of the 2006 clinical recommendations. This 2008 advisory statement concludes, on the basis of a review of the current literature, that for patients receiving bisphosphonate therapy, the risk of developing bisphosphonate-associated osteonecrosis (BON) of the jaw apparently remains low. It also newly concludes that current screening and diagnostic tests are unreliable for predicting a patient's risk of developing the condition. This statement updates the 2006 recommendations regarding general dentistry, management of periodontal diseases, implant placement and maintenance, oral and maxillofacial surgery, endodontics, restorative dentistry and prosthodontics, and orthodontics.

Jaw Diseases - diagnosis

Osteonecrosis - diagnosis

Osteonecrosis - therapy

Bone Density Conservation Agents - adverse effects

United States

Humans

Jaw Diseases - prevention & control

Jaw Diseases - therapy

Bone Density Conservation Agents - therapeutic use

Osteoporosis - drug therapy

Dental Care

Dental Care for Chronically Ill

Jaw Diseases - chemically induced

Diphosphonates - therapeutic use

Osteonecrosis - chemically induced

Osteonecrosis - prevention & control

Diphosphonates - adverse effects

American Dental Association

Practice Guidelines as Topic

Details

Title: Subtitle: Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs
Creators: Beatrice J Edwards - Department of Medicine and Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, USA
John W Hellstein
Peter L Jacobsen
Steven Kaltman
Angelo Mariotti
Cesar A Migliorati
Resource Type: Journal article
Publication Details: The Journal of the American Dental Association (1939), Vol.139(12), pp.1674-1677
DOI: 10.14219/jada.archive.2008.0110
PMID: 19047674
NLM abbreviation: J Am Dent Assoc
ISSN: 0002-8177
eISSN: 1943-4723
Publisher: American Dental Association; England
Language: English
Date published: 12/2008
Academic Unit: Oral Pathology, Radiology and Medicine
Record Identifier: 9984065800802771

Metrics

20 Record Views

121 Times Cited - Web of Science

See more details